 Home > Medical News > Medicines Company News > Over 1.3 billion US dollars! Biogen and Capsigen collaborate to develop gene therapy

Over 1.3 billion US dollars! Biogen and Capsigen collaborate to develop gene therapy

 Last Update: 2021-07-06
 Source: Internet
 Author: User

Tags

gene therapy news

cell therapy manufacturing

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Biogen and Capsigen recently announced that the two companies have signed a strategic research cooperation agreement to design a new type of adeno-associated virus capsids (AAVcapsids) with the potential to deliver transformative gene therapies to address a variety of central nervous systems and nerves.
Potential genetic causes of muscle diseases
.
This collaboration is intended to treat central nervous system and neuromuscular diseases

According to the terms of the agreement, Capsigen will apply its vector engineering methods to develop highly customized new capsids that meet the characteristics of disease-specific transduction
.
Bojian will obtain the exclusive license of Capsigen's proprietary technology to develop gene therapies that target multiple (undisclosed numbers) of central nervous system and neuromuscular diseases

It is understood that this collaboration will use Capsigen's proprietary TRADE platform and related technologies to create and identify customized new adeno-associated virus capsids that meet disease-specific transduction characteristics
.
The capsid is the protein coat of the virus, which can protect and promote the gene load of the virus into the host cell

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.